Form 4 for ISRG Intuitive Surgical
Accepted 2022-01-26 00:00:00 ET · period of report 2022-01-25 · accession 0001035267-22-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-26 | 2022-01-25 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $124.50 | +6,000 | 3,285 | New | +$747.0K |
| DM | 2022-01-26 | 2022-01-25 | ISRG | Curet Myriam | EVP, Chief Medical Off | S - Sale+OE | $263.94 | -6,000 | 285 | -95% | -$1.58M |
| DM | 2022-01-26 | 2022-01-25 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $0.00 | -6,000 | 15.0K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-25 | M | A | 3,000 | $139.52 | 3,285 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-25 | S | D | 3,000 | $263.94 | 285 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $261.60 to $266.71 as follows: 953 shares sold at $261.60 to $261.67; 1,447 shares sold at $262.30 to $262.80; 900 shares sold at $263.12 to $263.20; 829 shares sold at $264.575 to $265.44; 671 shares sold at $265.44 to 265.74, and 1,200 shares sold at $266,11 to $266.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2022-01-25 | M | A | 3,000 | $109.49 | 3,285 | D | — | — | |
| 4 | Common | Common Stock | 2022-01-25 | S | D | 3,000 | $263.94 | 285 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $261.60 to $266.71 as follows: 953 shares sold at $261.60 to $261.67; 1,447 shares sold at $262.30 to $262.80; 900 shares sold at $263.12 to $263.20; 829 shares sold at $264.575 to $265.44; 671 shares sold at $265.44 to 265.74, and 1,200 shares sold at $266,11 to $266.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-01-25 | M | D | 3,000 | $0.00 | 0 | D | $109.49 · — to 2027-08-15 | 3,000 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-01-25 | M | D | 3,000 | $0.00 | 15,000 | D | $139.52 · — to 2028-02-15 | 3,000 Common Stock | (F4) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |